Resultados de la búsqueda 121-130 of 4923 for Two-phase

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... Phase 2 part to further assess the effectiveness and safety of JCAR017 ... stage at progression, secondary metastases including brain metastases (at ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Randomized Phase II/III Trial of Adjuvant ... A Study to Compare Two Surgical Procedures in Women With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer.

  4. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor ...

  5. Neurología - Ensayos clínicos

    ... Phase 2b clinical trial. Primary Tumor Research ... There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... phase 2 dose (RP2D) of APG-2575. A Study to Evaluate Immunotherapy and Ovarian Function Among Pre-menopausal Melanoma Survivors. Rochester, Minn. The ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL). Rochester, Minn. The purpose of ths study is to find out more about ...

  8. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor ...

  9. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor ...

  10. Hematología - Ensayos clínicos

    The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma ...